Skip to main content
Veterinary Medicines

Xylazine 2% 20 mg/ml šķīdums injekcijām liellopiem, zirgiem, aitām, suņiem, kaķiem

Authorised
  • Xylazine hydrochloride

Product identification

Medicine name:
Xylazine 2% 20 mg/ml šķīdums injekcijām liellopiem, zirgiem, aitām, suņiem, kaķiem
Active substance:
  • Xylazine hydrochloride
Target species:
  • Cat
  • Dog
  • Cattle
  • Horse
  • Sheep
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Xylazine hydrochloride
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cat
    • Dog
    • Cattle
      • Not specified
        0
        day
    • Horse
      • Not specified
        0
        day
    • Sheep
      • Not specified
        0
        day
  • Intravenous use
    • Dog
    • Horse
      • Not specified
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN05CM92
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Alfasan International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfasan International B.V.
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/NRP/97/0544
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 16/01/2025

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 16/01/2025

Labelling

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 16/01/2025
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."